A parallel study illustrated that serum CCL19 levels might reflect blood B cell imbalance and correlate to the levels of some serum B cell biomarkers, such as rheumatoid factor, anti-CCP, free light chains, IgG, IgA and IgM, in RA patients. This evidence concerns the gene CCL19 and rheumatoid arthritis.